Cargando…

Patient Characteristics and Clinical Outcomes with Low-Dose Dabigatran

BACKGROUND/AIMS: Dabigatran, an oral direct thrombin inhibitor, is used in patients with non-valvular atrial fibrillation to reduce thromboembolic events. Whereas the 150 mg dosing regimen has been extensively studied in clinical setting, to date, there is no clinical data on the 75 mg (low dose, “L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ebrahimi, Ramin, Han, Janet K., Goe, Seung H., Treadwell, Michelle, Feliciano, Zenaida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502329/ https://www.ncbi.nlm.nih.gov/pubmed/28740848 http://dx.doi.org/10.3389/fcvm.2017.00042

Ejemplares similares

Impact of Renal Function on Effectiveness and Safety Associated With Low Dose Dabigatran in Non-valve Atrial Fibrillation Patients After Catheter Ablation
por: Li, Xiaoye, et al.
Publicado: (2021)

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study
por: Sørensen, Rikke, et al.
Publicado: (2013)

Population pharmacokinetic analysis for dabigatran etexilate in Chinese patients with non-valvular atrial fibrillation
por: Liu, Ya-ou, et al.
Publicado: (2022)

Hemoclot Thrombin Inhibitor Assay and Expected Peak-Trough Levels of Dabigatran: A Multicenter Study
por: Liu, Zhiyan, et al.
Publicado: (2022)

Peri-interventional Triple Therapy With Dabigatran Improves Vasomotion and Promotes Endothelialization in Porcine Coronary Stenting Model
por: Hemetsberger, Rayyan, et al.
Publicado: (2021)

Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation
por: Huber, K, et al.
Publicado: (2013)

Dabigatran for left atrial thrombus
por: Morita, Sae, et al.
Publicado: (2013)

Association between CES1 rs2244613 and the pharmacokinetics and safety of dabigatran: Meta-analysis and quantitative trait loci analysis
por: Li, Haobo, et al.
Publicado: (2022)

Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database
por: Lee, Sally, et al.
Publicado: (2012)

Protocol, rationale and design of DAbigatran for Stroke PreVention In Atrial Fibrillation in MoDerate or Severe Mitral Stenosis (DAVID-MS): a randomised, open-label study
por: Zhou, Mi, et al.
Publicado: (2020)

Characteristics, outcomes, and predictors of de novo malignancy after heart transplantation
por: Youn, Jong-Chan, et al.
Publicado: (2022)

Boehringer launches first direct thrombin inhibitor: dabigatran (Pradaxa®)
Publicado: (2010)

Acute Myocardial Infarction During the COVID-19 Pandemic: An Update on Clinical Characteristics and Outcomes
por: Toscano, Olga, et al.
Publicado: (2021)

Endothelial Phenotype Evoked by Low Dose Carvedilol in Pulmonary Hypertension
por: Cheong, Hoi I, et al.
Publicado: (2018)

Bilateral Pulmonary Emboli on Dabigatran
por: Clark, Emily, et al.
Publicado: (2021)

Chronic Low-Dose Alcohol Consumption Promotes Cerebral Angiogenesis in Mice
por: Li, Jiyu, et al.
Publicado: (2021)

Evaluation of low-dose colchicine in patients with cardiopulmonary bypass: study protocol for a randomised controlled trial
por: Zhang, He, et al.
Publicado: (2022)

Low-dose and standard-dose ticagrelor compared with clopidogrel in patients with acute coronary syndromes: A cohort study from china
por: Peng, Wenxing, et al.
Publicado: (2022)

South African experts comment on FDA approval of dabigatran inatrial fibrillation
por: E, Klug, et al.
Publicado: (2011)

Fulminant Giant Cell Myocarditis vs. Lymphocytic Myocarditis: A Comparison of Their Clinical Characteristics, Treatments, and Outcomes
por: Hu, Yuxiao, et al.
Publicado: (2021)

Clinical significance of substrate characteristics and ablation outcomes in patients with atrial fibrillation and significant functional mitral regurgitation
por: Bautista, Jose Antonio L., et al.
Publicado: (2023)

Study on the safety and effectiveness of low-dose vs. regular-dose fondaparinux in preventing venous thromboembolism prophylaxis following total knee arthroplasty
por: Chen, Ping-bo, et al.
Publicado: (2023)

Sex-Specific Clinical Characteristics and Long-Term Outcomes in Patients With Myocardial Infarction With Non-obstructive Coronary Arteries
por: Gao, Side, et al.
Publicado: (2021)

Low-dose aspirin in the prevention of preeclampsia in twin pregnancies: A real-world study
por: Zhou, Qiongjie, et al.
Publicado: (2023)

Association of frailty status with adverse clinical outcomes in patients with COVID-19: protocol for a systematic review and dose–response meta-analysis
por: Pei, Hanjun, et al.
Publicado: (2021)

Catheter ablation in Asian patients with atrial fibrillation and hypertrophic cardiomyopathy: electrophysiological characteristics of recurrence and long-term clinical outcomes
por: Lin, Chih-Hsien, et al.
Publicado: (2023)

Low-molecular-weight heparin in addition to low-dose aspirin for preventing preeclampsia and its complications: A systematic review and meta-analysis
por: Zheng, Li, et al.
Publicado: (2022)

Comparison between thoracic low-dose computed tomography and conventional-dose computed tomography in evaluating anemia: A preliminary study in a Chinese screening cohort
por: Zhang, Jianing, et al.
Publicado: (2022)

Infective Endocarditis: Clinical Characteristics and Echocardiographic Findings
por: Poorzand, Hoorak, et al.
Publicado: (2022)

Case report: First-in-human combined low-dose whole-heart irradiation and high-dose stereotactic arrhythmia radioablation for immunosuppressive refractory cardiac sarcoidosis and ventricular tachycardia
por: van der Ree, Martijn H., et al.
Publicado: (2023)

Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease
por: Khan, Hamzah, et al.
Publicado: (2022)

Cardiac and vascular effects of low-dose steroids during the early phase of septic shock: An echocardiographic study
por: Bagate, François, et al.
Publicado: (2022)

The Characteristics, Long-Term Outcomes, Risk Factors, and Antithrombotic Therapy in Chinese Patients With Atrial Fibrillation and Bioprosthetic Valves
por: Ren, Jiameng, et al.
Publicado: (2021)

Clinical characteristics, precipitating factors, management and outcome of patients with prior stroke hospitalised with heart failure: an observational report from the Middle East
por: Khafaji, Hadi A R, et al.
Publicado: (2015)

Clinical Characteristics and Long-Term Outcomes of MINOCA Accompanied by Active Cancer: A Retrospective Insight Into a Cardio-Oncology Center Registry
por: Stepien, Konrad, et al.
Publicado: (2022)

FDA committee unanimously recommends approval of dabigatran etexilate for stroke prevention in atrial fibrillation
por: J, Aalbers, et al.
Publicado: (2010)

Mitral valve aneurysms: echocardiographic characteristics, formation mechanisms, and patient outcomes
por: Wang, Yi, et al.
Publicado: (2023)

Clinical characteristics of patients with heart failure and intracardiac thrombus
por: Zhai, Mei, et al.
Publicado: (2022)

Clinical Characteristics and Long-Term Outcomes of Patients With Differing Haemoglobin Levels Undergoing Semi-Urgent and Elective Percutaneous Coronary Intervention in an Asian Population
por: Soh, Rodney Yu-Hang, et al.
Publicado: (2022)

Clinical characteristics and outcomes in patients with Takayasu arteritis coexisting with myocardial ischemia and neurological symptoms: A multicenter, long-term, follow-up study
por: Huo, Junting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_shntb6ptgs6qcvirjks50ankir